Laser and light treatments are among the most searched options for dark spots. The names can be hard to sort out: picosecond, Q-switched, Nd:YAG, IPL, laser toning. Each device works in its own way, and the evidence differs depending on what kind of pigmentation is being treated.

This guide explains the main pigment devices in plain terms and summarizes what published studies and dermatology references report. It does not replace an assessment. Whether any device is suitable depends on your diagnosis, skin type and history, so talk to a dermatologist before booking a procedure.

Start with the diagnosis

The same device can help one type of pigmentation and worsen another. Two points from DermNet set the scene:

  • Sun spots (solar lentigines) are harmless, and pigment-specific lasers and intense pulsed light are among the cosmetic options.
  • Melasma carries a high risk of relapse after lasers, IPL and microneedling, and the condition can become more resistant, so these procedures need expert use.

Getting the diagnosis right also protects you from missing something serious. DermNet notes that atypical sun spots can be hard to tell apart from early melanoma, and that a biopsy is advised when there is doubt. Its IPL page likewise stresses confirming the diagnosis before treatment.

Very close view of warm brown skin showing pores and two small moles
Skin type is one of the things that decides whether a device is suitable at all. Photo: Mathaus Heringer / Unsplash

How pigment devices work

Pigment devices deliver light that melanin absorbs. As DermNet describes for IPL, the absorbed light heats the pigment, which then breaks down. Lasers do this with a single wavelength.

Pulse length matters. The 2020 split-face trial in Annals of Dermatology explains that melanosomes (the tiny packages that hold melanin) take roughly 50 to 250 nanoseconds to lose heat. That is why nanosecond-length pulses have long been the standard for sun spots.

Q-switched lasers

Q-switched lasers deliver very short, high-energy pulses in the nanosecond range (about 5 to 100 nanoseconds). Common types include Nd:YAG (532 nm and 1064 nm), ruby and alexandrite.

The same paper notes a drawback. These bursts can also heat nearby blood vessels and pigment, causing inflammation that may lead to post-inflammatory hyperpigmentation (PIH).

Picosecond lasers

Picosecond lasers use even shorter pulses, around 300 to 900 picoseconds. According to the 2020 trial authors, they produce a stronger photomechanical effect and spread less heat into surrounding tissue. In other words, they rely more on mechanical breakup of pigment and less on heat.

Intense pulsed light (IPL)

DermNet points out that IPL is not a laser. It delivers many wavelengths of visible light in each pulse, refined with filters, rather than a single wavelength. Melanin absorbs the light, heats and breaks down.

DermNet lists age spots, freckles, flat pigmented birthmarks and melasma among its pigment uses. A course may involve 4 to 6 sessions spaced 3 to 6 weeks apart.

Quick comparison

Device Pulse or output Main pigment uses in the sources Key cautions
Q-switched laser Nanosecond pulses, single wavelength Sun spots; low-fluence use in some melasma studies PIH; in melasma, rebound, mottled light spots and fast relapse
Picosecond laser Picosecond pulses, single wavelength Sun spots Melasma data limited in the reviews cited here
IPL Broad spectrum of visible light, filtered Age spots, freckles, some melasma Blistering, darker or paler patches, relapse in melasma
A practitioner talking with a seated patient in a bright treatment room
The choice of device is usually made at a consultation, not on the day of treatment. Photo: Sum Sum / Unsplash

What studies report for sun spots

The 2020 randomized split-face trial treated 20 women with Fitzpatrick skin types III to V. Each had one side of the face treated with a 532 nm picosecond laser and the other with a 532 nm Q-switched Nd:YAG laser, in a single session.

At 12 weeks:

  • Blinded dermatologists rated clearance higher on the picosecond side.
  • PIH appeared on 5% of picosecond-treated sides and 30% of Q-switched sides. This difference did not reach statistical significance.
  • Satisfaction and pain scores were similar.

The authors concluded that both lasers were safe and effective, with the picosecond laser clearing spots more effectively. The study was small and did not use biopsies to confirm the diagnosis.

What studies report for melasma

A 2017 review of laser and light therapy in melasma in the International Journal of Women’s Dermatology brings together many small studies. Its overall findings are sobering:

  • Roughly half of patients relapse to some degree within 3 to 6 months, regardless of device.
  • Q-switched lasers relapse fastest, IPL at an intermediate rate and non-ablative fractional lasers most slowly.
  • Laser and light therapy are positioned as third-line options, after topical treatments and chemical peels. They are not cures.

Q-switched lasers in melasma

Older high-energy Q-switched treatments were largely ineffective and often caused rebound darkening or PIH, according to the review. Later studies used low-fluence 1064 nm Q-switched Nd:YAG, often called laser toning.

Results show the trade-off. In one split-face study, lightness improved markedly on the laser side, but some patients developed mottled or confetti-like pale spots, and recurrence was 100% at three months. Another study reported a 61.3% MASI reduction with 64% recurrence at three months. The review’s authors reserve Q-switched treatment for very stubborn cases.

IPL in melasma

Studies combining IPL with topical lightening agents reported better results than either alone. The reviewers note IPL suits lighter skin types (Fitzpatrick I to III) and works better for epidermal than mixed melasma.

Picosecond lasers in melasma

At the time of the 2017 review, no melasma efficacy data for picosecond lasers had been published. The authors listed them as a promising future option. DermNet’s melasma page groups picosecond lasers with other devices that carry a high relapse risk.

Risks to know about

Across the sources, reported risks include:

  • PIH: DermNet notes physical treatments can worsen PIH by injuring the skin.
  • Lighter patches: BAD warns lasers can leave patches of lighter skin, more often in people of color.
  • Rebound darkening: reported especially in melasma.
  • IPL-specific effects: pain, redness, a sunburn-like feeling, rare blistering, and bruising in up to 10% of patients, according to DermNet.

Steps that lower risk

The sources point to several practical safeguards:

  • Confirm the diagnosis with a dermatologist first.
  • For melasma, DermNet advises pre-treatment with a tyrosinase inhibitor such as hydroquinone, and the 2017 review reports that topical therapy before and after procedures improves outcomes and lowers rebound and PIH risk.
  • Avoid sun exposure before and after treatment, as DermNet advises for IPL.
  • Choose a highly experienced operator, as BAD recommends.

Prescription lightening creams and procedure plans should be discussed with a dermatologist who can examine your skin.

A young woman in a treatment chair looking at her face in a hand mirror
Looking at the skin again between sessions, before deciding on the next one. Photo: Sum Sum / Unsplash

Setting expectations

For well-defined sun spots, pigment lasers and IPL have reasonable evidence, with PIH as the main risk. For melasma, devices may help some people, but relapse is common and the reviewed evidence places them after topical treatments and peels. Ongoing sun protection supports any result.

Sources

  1. A Split-Face, Single-Blinded, Randomized Controlled Comparison of 532 nm Picosecond Nd:YAG Laser versus 532 nm Q-Switched Nd:YAG Laser in the Treatment of Solar Lentigines Annals of Dermatology (via PMC)
  2. A review of laser and light therapy in melasma International Journal of Women's Dermatology (via PMC)
  3. Intense pulsed light therapy DermNet
  4. Solar lentigo DermNet
  5. Melasma (facial pigmentation) DermNet
  6. Postinflammatory hyperpigmentation DermNet
  7. Melasma patient information leaflet (June 2024) British Association of Dermatologists

This article is general information, not medical advice. It does not replace an examination, and treatment for pigmentation should be planned with a dermatologist or another qualified clinician who has seen your skin.